pixlbio logo

pixlbio

pixl x bio: from cells to pixels to predictions

21 employees · est. 2025 · Uppsala, Sweden

VS
Tract Bio logo

Tract Bio

Discovering and developing novel therapies to transform the treatment of cancer and inflammatory disease.

2 employees · Boston, United States

pixlbio is the larger of the two.

Side-by-Side Comparison

pixlbio Tract Bio
Founded
2025 Not tracked yet
Headquarters
Uppsala, Sweden Boston, United States
Employees
21 larger 2
Industry
Biotechnology, Health Care, Pharmaceutical Health and Wellness, Life Sciences, Pharmaceutical
Funding Stage
Series A Not tracked yet
Total Funding
$11.53M Not tracked yet
Funding Rounds
6 Not tracked yet
Services
iPSC-derived Models, High-content Phenomic Analysis, Custom Studies and Analytics, Automated Experimentation, Predictive Modeling Not tracked yet
Target Customers
Biopharma Companies, Pharmaceutical Corporations, Research Institutions Not tracked yet
Taxonomy
IPSC-derived Human Models, High-throughput Imaging, AI-powered Phenomics, Drug Discovery, Safety Testing, Disease Modeling, Regenerative Medicine, Hepatocytes, Intestinal Organoids, Automated Phenomics, ISO 9001:2015 Certification, CRISPR Gene Editing, Toxicology Testing, Cell Painting Cancer Therapy, Inflammatory Disease Treatment, Stem Cell Research, Drug Discovery, Esophageal Adenocarcinoma, Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Gastric Cancer, COPD, Idiopathic Pulmonary Fibrosis, Cystic Fibrosis, Crohn's Disease, Novel Drug Development
Website
pixl.bio tractbio.com
pixlbio logo

About pixlbio

pixlbio, born from the merger of DefiniGEN and Phenaros, is pioneering the field of predictive biology by merging iPSC-derived human models with cutting-edge technologies such as high-throughput imaging and AI-powered phenomics. They are setting new standards in drug discovery and safety by capturin...

Tract Bio logo

About Tract Bio

Tract Bio is a biotechnology company focused on discovering and developing novel therapies to revolutionize the treatment of cancer and inflammatory diseases. The company's proprietary stem cell discovery platform, stemECHO™, enables the generation of pure stem cell libraries in their ground-state w...

We will tell you when either one moves

BounceWatch watches pixlbio and Tract Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at pixlbio and Tract Bio — by email.

Frequently Asked Questions

pixlbio — pixl x bio: from cells to pixels to predictions. Tract Bio — Discovering and developing novel therapies to transform the treatment of cancer and inflammatory disease.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
pixlbio has raised $11.53M while Tract Bio has raised undisclosed funding.
pixlbio and Tract Bio operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare pixlbio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at pixlbio on 25 Mar 2026, and Tract Bio on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy